Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Serum hsCRP and visfatin are elevated and correlate to carotid arterial stiffness in spinal cord-injured subjects.

La Favor JD, Hollis BC, Mokshagundam SL, Olive JL.

Spinal Cord. 2011 Sep;49(9):961-6. doi: 10.1038/sc.2011.56. Epub 2011 May 31.

PMID:
21625240
2.

The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.

Kadoglou NP, Gerasimidis T, Golemati S, Kapelouzou A, Karayannacos PE, Liapis CD.

J Vasc Surg. 2008 Jan;47(1):55-62. doi: 10.1016/j.jvs.2007.09.058.

3.

C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury.

Lee MY, Myers J, Hayes A, Madan S, Froelicher VF, Perkash I, Kiratli BJ.

J Spinal Cord Med. 2005;28(1):20-5.

PMID:
15832900
4.

Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.

Filippatos TD, Tsimihodimos V, Derdemezis CS, Gazi IF, Saougos V, Mikhailidis DP, Tselepis AD, Elisaf MS.

Nutr Metab Cardiovasc Dis. 2013 Apr;23(4):330-6. doi: 10.1016/j.numecd.2011.07.002. Epub 2011 Oct 2.

PMID:
21963513
5.

Fasting serum levels of adiponectin, ghrelin, and leptin in men with spinal cord injury.

Wang YH, Huang TS, Liang HW, Su TC, Chen SY, Wang TD.

Arch Phys Med Rehabil. 2005 Oct;86(10):1964-8. Erratum in: Arch Phys Med Rehabil. 2007 May;88(5):688.

PMID:
16213239
6.

Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.

Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M.

Adv Med Sci. 2008;53(1):32-6. doi: 10.2478/v10039-008-0024-x.

PMID:
18635422
7.

Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy.

Eyileten T, Sonmez A, Saglam M, Cakir E, Caglar K, Oguz Y, Vural A, Yenicesu M, Yilmaz MI.

Nephrology (Carlton). 2010 Mar;15(2):225-9. doi: 10.1111/j.1440-1797.2009.01173.x.

PMID:
20470283
8.

Associations of plasma homocysteine and high-sensitivity C-reactive protein levels with arterial stiffness in Chinese population: a community-based study.

Feng SQ, Ye P, Luo LM, Xiao WK, Bai YY, Feng D, Liu DJ, Wu HM, Xu RY, Bai J.

Chin Med J (Engl). 2012 Jan;125(1):44-9.

PMID:
22340464
9.

Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.

Tang X, Chen M, Zhang W.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Jun;38(6):553-9. doi: 10.3969/j.issn.1672-7347.2013.06.002.

10.

Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.

Chu CH, Lee JK, Wang MC, Lu CC, Sun CC, Chuang MJ, Lam HC.

Metabolism. 2008 Oct;57(10):1380-3. doi: 10.1016/j.metabol.2008.05.006.

PMID:
18803942
11.

Circulating visfatin level is correlated with inflammation, but not with insulin resistance.

Oki K, Yamane K, Kamei N, Nojima H, Kohno N.

Clin Endocrinol (Oxf). 2007 Nov;67(5):796-800. Epub 2007 Jul 18.

PMID:
17634078
12.

The relationship between inflammation and arterial stiffness in patients with essential hypertension.

Kampus P, Muda P, Kals J, Ristimäe T, Fischer K, Teesalu R, Zilmer M.

Int J Cardiol. 2006 Sep 10;112(1):46-51. Epub 2005 Nov 17.

PMID:
16297996
13.

Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes.

Kang ES, Kim HJ, Kim YM, Lee S, Cha BS, Lim SK, Kim HJ, Lee HC.

Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S115-20.

PMID:
15563960
14.

Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension.

Pietri P, Vyssoulis G, Vlachopoulos C, Zervoudaki A, Gialernios T, Aznaouridis K, Stefanadis C.

J Hypertens. 2006 Nov;24(11):2231-8.

PMID:
17053545
15.

Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.

Duprez DA, Somasundaram PE, Sigurdsson G, Hoke L, Florea N, Cohn JN.

J Hum Hypertens. 2005 Jul;19(7):515-9.

PMID:
15905893
16.

Aortic arterial stiffness is a moderate predictor of cardiovascular disease in patients with psoriasis vulgaris.

Balta I, Balta S, Demirkol S, Celik T, Ekiz O, Cakar M, Sarlak H, Ozoguz P, Iyisoy A.

Angiology. 2014 Jan;65(1):74-8. doi: 10.1177/0003319713485805. Epub 2013 May 1.

PMID:
23636854
17.

Visfatin and endothelial function in dialyzed patients.

Malyszko J, Malyszko JS, Mysliwiec M.

Nephrology (Carlton). 2010 Mar;15(2):190-6. doi: 10.1111/j.1440-1797.2009.01180.x.

PMID:
20470278
18.

Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke.

Lu LF, Yang SS, Wang CP, Hung WC, Yu TH, Chiu CA, Chung FM, Shin SJ, Lee YJ.

J Stroke Cerebrovasc Dis. 2009 Sep-Oct;18(5):354-9. doi: 10.1016/j.jstrokecerebrovasdis.2009.01.003.

PMID:
19717018
19.

Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women.

Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Dendrinos S, Augoulea A, Papamichael C, Lambrinoudaki I.

Metabolism. 2012 Feb;61(2):193-201. doi: 10.1016/j.metabol.2011.06.005. Epub 2011 Aug 4.

PMID:
21820132
20.

Supplemental Content

Support Center